Skip to search formSkip to main contentSkip to account menu

inolimomab

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Service thérapie cellulaire et hématologie clinique, CHU, Clermont-Ferrand, France; 7 Unité de Transplantation et de Thérapie… 
2008
2008
1. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J… 
2007
2007
Background and objectiveInolimomab, a monoclonal antibody against interleukin (IL)-2Rα (CD25) has shown promising results in the… 
2006
2006
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2005
2005
Background. The use of monoclonal antibodies against interleukin-2 receptor (IL-2R)-α chains could be an effective treatment of… 
Review
2002
Review
2002
OPi (formerly Orphan Pharma International) is developing inolimomab, an anti-interleukin-2 receptor (CD25) monoclonal antibody… 
1997
1997
SummaryMonoclonal and polyclonal antibody preparations have been used for induction therapy after organ transplantation. Apart…